Compare Brookfield Infrastructure Partners LP (BIP) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brookfield Infrastructure Partners LP vs Moderna, Inc. — how do they compare? Brookfield Infrastructure Partners LP trades at $39 (market cap $18.10B), while Moderna, Inc. trades at $60.75 (market cap $24.18B). The key difference: Moderna, Inc. is the larger of the two by market cap, and Brookfield Infrastructure Partners LP pays a 4.62% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| BIP | MRNA | |
|---|---|---|
Market Cap | $18.10B | $24.18B |
Sector | Industrials | Health |
52-Week High | $42.62 | $81.80 |
52-Week Low | $29.81 | $22.36 |
Enterprise Value | $77.05B | $20.33B |
Dividend Yield | 4.62% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Brookfield Infrastructure Partners LP
Brookfield Infrastructure owns and operates high-quality global assets across utilities, transport, midstream, and data sectors. It focuses on generating stable, long-term cash flows from essential infrastructure.
Read more on BIP →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
